在Europella研究中,选取了144例在Impella 2.5的支持下进行PCI治疗的高危冠心病患者,结果显示,Impella 2.5可安全有效地用于高危PCI患者,能够有效预防术中血流动力学障碍。因此目前美国FDA已批准Impella 2.5用于择期高危PCI中血流动力学支持。 小结 随着高危PCI的广泛开展,循环支持的地位日渐...
PCI-SIG Developers Conference Europe 2018 May 7-8, 2018 Hotel Vier Jahreszeiten Kempinski Munich Munich, Germany PCI-SIG Compliance Workshop #105 April 24-27, 2018 Embassy Suites Burlingame Burlingame, California PCI-SIG Compliance Workshop #104 December 5-8, 2017 Embassy Suites Burlingame Burl...
高危PCI患者应用Impella 2.5也显示出了良好的临床效果。在Europella研究中,选取了144例在Impella 2.5的支持下进行PCI治疗的高危冠心病患者,结果显示,Impella 2.5可安全有效地用于高危PCI患者,能够有效预防术中血流动力学障碍。因此目前美国FDA已批准Impella 2.5用于择期高危PCI中血流...
PCI’s integrated energy management platform consolidates all multi-commodity trading activities in a single system, providing full transparency and optimization across power, fuels, and more. Our modular, cloud-first solutions are tailored to each customer’s needs, anchored by expert support that ev...
12thHPCI Central and Eastern Europe EXHIBITION AND CONFERENCE 27-28 September 2023, EXPO XXI, Warsaw, Poland, Hall 4 13 New Main Exhibitors in 2023! * Over 350 represented companies! Record-breaking attendance of 1.300 Professionals! HPCI CEE 2023 Poster Session Winners Announced!
eeNews Europe (August 2, 2023) PCI Express looks to optical links Tom’s Hardware (August 2, 2023) PCIe at the Speed of Light: PCI-SIG Forms Optical Workgroup PCWorld (August 2, 2023) PCI Express explores PC tech that will run on light EE Times (July 30, 2023) PCIe Eyes Road...
高危PCI患者应用Impella 2.5也显示出了良好的临床效果。在Europella研究中,选取了144例在Impella 2.5的支持下进行PCI治疗的高危冠心病患者,结果显示,Impella 2.5可安全有效地用于高危PCI患者,能够有效预防术中血流动力学障碍。因此目前美国FDA已批准Impella 2.5用于择期高危PCI中血流动力学支持。
Contemporary PCI practices across three continents: Europe, Asia and South-AmericaContemporary PCI practices across three continents: Europe, Asia and South-America - 2013 - Lectures - PCRonlineJ., PoladF.T.N., MalikJ., GasparL.A., Piva Mattos...
高危PCI患者应用Impella 2.5也显示出了良好的临床效果。在Europella研究中,选取了144例在Impella 2.5的支持下进行PCI治疗的高危冠心病患者,结果显示,Impella 2.5可安全有效地用于高危PCI患者,能够有效预防术中血流动力学障碍。因此目前美国FDA已批准Impella 2.5用于择期高危PCI中血流动力学支持。
East Asia (e.g. China, Japan, Korea) Europe - EU countries Europe - non EU (e.g. UK, Russia, ex-CIS countries) South America (e.g. Brazil, Colombia) South Asia (e.g. India, Pakistan, Sri Lanka) South East Asia (e.g. Thailand, Philippines, Singapore) ...